TENSART HCT

This brand name is authorized in Lithuania, Poland

Active ingredients

The drug TENSART HCT contains a combination of these active pharmaceutical ingredients (APIs):

1 Valsartan UNII 80M03YXJ7I - VALSARTAN

Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II. Read about Valsartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA03	Valsartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005166, 1032877, 1032878, 1032879, 1032880, 1032881, 1032882, 1036709, 1036710, 1036711, 1036712, 1036713, 1036714, 1036715, 1036716, 1036717, 1036718, 1036719, 1036720, 1036721, 1036722, 1036723, 1036724, 1036725, 1036726, 1036727, 1036728, 1036729, 1036730, 1036731, 1036732, 1036733, 1036734, 1036735, 1036736, 1036737, 1036738, 1036739, 1036740, 1036741, 1036742, 1036743
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100210183, 100210190